{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:32:15Z","timestamp":1740126735904,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["104-2320-B-016-012-MY3"],"award-info":[{"award-number":["104-2320-B-016-012-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taoyuan General Hospital, Ministry of Health and Welfare","award":["10602"],"award-info":[{"award-number":["10602"]}]}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jocn.2017.08.010","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T18:16:19Z","timestamp":1504808179000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The association between scabies and myasthenia gravis: A nationwide population-based cohort study"],"prefix":"10.1016","volume":"45","author":[{"given":"Ren-Jun","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fung-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Fa","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Chang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2017.08.010_b0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-4017(87)90104-X","article-title":"The history of scabies in veterinary and human medicine from biblical to modern times","volume":"25","author":"Roncalli","year":"1987","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.jocn.2017.08.010_b0010","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMcp052784","article-title":"Scabies","volume":"354","author":"Chosidow","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2017.08.010_b0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(06)68772-2","article-title":"Scabies","volume":"367","author":"Heukelbach","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2017.08.010_b0020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jocn.2017.08.010_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000424240","article-title":"Scabies: what's new?","volume":"22","author":"Orkin","year":"1995","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jocn.2017.08.010_b0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03798.x","article-title":"Scabies in the developing world\u2013its prevalence, complications, and management","volume":"18","author":"Hay","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jocn.2017.08.010_b0035","doi-asserted-by":"crossref","first-page":"e0003452","DOI":"10.1371\/journal.pntd.0003452","article-title":"Scabies and impetigo prevalence and risk factors in Fiji: a national survey","volume":"9","author":"Romani","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jocn.2017.08.010_b0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0950268899002277","article-title":"The epidemiology of head lice and scabies in the UK","volume":"122","author":"Downs","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jocn.2017.08.010_b0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00128071-200405010-00005","article-title":"Controlling scabies in institutional settings: a review of medications, treatment models, and implementation","volume":"5","author":"Scheinfeld","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jocn.2017.08.010_b0050","doi-asserted-by":"crossref","first-page":"e0136789","DOI":"10.1371\/journal.pone.0136789","article-title":"The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma","volume":"10","author":"Bowen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2017.08.010_b0055","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2147\/COPD.S114256","article-title":"Scabies increased the risk and severity of COPD: a nationwide population-based study","volume":"11","author":"Chen","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jocn.2017.08.010_b0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jdv.12099","article-title":"Scabies increased the risk of chronic kidney disease: a 5-year follow-up study","volume":"28","author":"Chung","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jocn.2017.08.010_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jocn.2017.08.010_b0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4140\/TCP.n.2007.239","article-title":"Diagnosis and treatment of myasthenia gravis","volume":"22","author":"Matney","year":"2007","journal-title":"Consult Pharm"},{"key":"10.1016\/j.jocn.2017.08.010_b0075","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2017.08.010_b0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jocn.2017.08.010_b0085","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mus.23271","article-title":"Geographical distribution of a seropositive myasthenia gravis population","volume":"45","author":"Heldal","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2017.08.010_b0090","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/mus.24348","article-title":"Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa","volume":"51","author":"Mombaur","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2017.08.010_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","article-title":"Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients","volume":"78","author":"Xie","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jocn.2017.08.010_b0100","doi-asserted-by":"crossref","first-page":"25886","DOI":"10.1038\/srep25886","article-title":"Changes in inflammatory cytokine networks in myasthenia gravis","volume":"6","author":"Uzawa","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2017.08.010_b0105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2017.08.010_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/sji.12057","article-title":"Expression of interleukin-22 in myasthenia gravis","volume":"78","author":"Zheng","year":"2013","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jocn.2017.08.010_b0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-4598(199705)20:5<543::AID-MUS2>3.0.CO;2-9","article-title":"Cytokines and the pathogenesis of myasthenia gravis","volume":"20","author":"Zhang","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2017.08.010_b0120","unstructured":"National Health Research Institutes. National Health Insurance Research Database (online). Available from: http:\/\/nhird.nhri.org.tw\/date_01.htm. Accessed October 1, 2015."},{"key":"10.1016\/j.jocn.2017.08.010_b0125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jad.2016.06.043","article-title":"The relationship between economic conditions and postpartum depression in Taiwan: a nationwide population-based study","volume":"204","author":"Chang","year":"2016","journal-title":"J Affect Disord"},{"issue":"suppl","key":"10.1016\/j.jocn.2017.08.010_b0130","first-page":"1","article-title":"Statistics NCfH. ICD-9-CM coding and reporting official guidelines. American Hospital Association, American Medical Record Association, Health Care Financing Administration, National Center for Health Statistics","volume":"61","author":"American Hospital Association","year":"1990","journal-title":"Journal (American Medical Record Association)"},{"key":"10.1016\/j.jocn.2017.08.010_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2017.08.010_b0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jocn.2017.08.010_b0145","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-gamma, and GM-CSF and Diminished IL-10 Production","volume":"196","author":"Cao","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2017.08.010_b0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ckj\/sft024","article-title":"Of mites and men: scabies in patients with kidney disease","volume":"6","author":"Tollitt","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jocn.2017.08.010_b0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0394632015627464","article-title":"Immunomodulatory impression of anti and pro-inflammatory cytokines in relation to humoral immunity in human scabies","volume":"29","author":"Abd El-Aal","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jocn.2017.08.010_b0160","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/pim.12129","article-title":"Crusted scabies is associated with increased IL-17 secretion by skin T cells","volume":"36","author":"Liu","year":"2014","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jocn.2017.08.010_b0165","doi-asserted-by":"crossref","first-page":"e0003498","DOI":"10.1371\/journal.pntd.0003498","article-title":"Prospective study in a porcine model of sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabies","volume":"9","author":"Mounsey","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jocn.2017.08.010_b0170","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1603\/033.046.0415","article-title":"Extracts of Sarcoptes scabiei De Geer downmodulate secretion of IL-8 by skin keratinocytes and fibroblasts and of GM-CSF by fibroblasts in the presence of proinflammatory cytokines","volume":"46","author":"Mullins","year":"2009","journal-title":"J Med Entomol"},{"key":"10.1016\/j.jocn.2017.08.010_b0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/QCO.0b013e32835eb8a6","article-title":"Immunology of scabies and translational outcomes: identifying the missing links","volume":"26","author":"Walton","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jocn.2017.08.010_b0180","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1164\/rccm.201410-1861OC","article-title":"IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis","volume":"191","author":"Roos","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jocn.2017.08.010_b0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario Canada","volume":"26","author":"Breiner","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jocn.2017.08.010_b0190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0196-0644(84)80522-3","article-title":"Drugs that may exacerbate myasthenia gravis","volume":"13","author":"Adams","year":"1984","journal-title":"Ann Emerg Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817309542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817309542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T10:38:38Z","timestamp":1565347118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817309542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":38,"alternative-id":["S0967586817309542"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.08.010","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between scabies and myasthenia gravis: A nationwide population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}